David J. Huss, PhD

Company: Shape Therapeutics

Job title: Chief Scientific Officer

Seminars:

Morning Q&A and Panel Discussion – Improving Delivery Performance 11:20 am

Your chance to ask this morning’s presenters follow up questions about their case studies Dive deeper into tailoring delivery of RNA editing Better understand the technology platformsRead more

day: Post-Conference Focus Day

Delivery Considerations for RNA Editing Payloads 10:20 am

Exploring delivery options for RNA editing payloads Tailoring delivery of RNA editing payloads to the target disease Highlighting ShapeTX AAVid capsid discovery platform enables tissue-specific delivery of gene-encoded RNA editing payloadsRead more

day: Post-Conference Focus Day